Kenvue Inc

KVUE

Company Profile

  • Business description

    Kenvue is the world’s largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson’s consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women’s health. Its portfolio includes a wide array of some of the most well-known brands in the space, including Tylenol, Listerine, Johnson’s, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue’s brands are the global leader in their respective segment thanks to their strong brand power.

  • Contact

    199 Grandview Road
    SkillmanNJ08558
    USA

    T: +1 908 874-1200

    https://www.kenvue.com

  • Sector

    Consumer Defensive

    Stock type

    Defensive

  • Industry

    Household & Personal Products

    Fiscal Year End

    31 December 2024

    Employees

    22,000

Kenvue Inc News & Analysis

stocks

9 best US dividend aristocrats to buy now

These undervalued stocks with wide and narrow moats have increased their dividends for 25 consecutive years or more.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,633.1066.100.77%
CAC 407,255.0141.690.58%
DAX 4019,322.59176.420.92%
Dow JONES (US)44,296.51426.160.97%
FTSE 1008,262.08112.811.38%
HKSE19,229.97371.14-1.89%
NASDAQ19,003.6531.230.16%
Nikkei 22538,283.85257.680.68%
NZX 50 Index13,041.90276.662.17%
S&P 5005,969.3420.630.35%
S&P/ASX 2008,393.8070.800.85%
SSE Composite Index3,267.19103.21-3.06%

Market Movers